Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma.
Saved in:
| Title: | Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma. |
|---|---|
| Authors: | Belge Bilgin, Gokce1 (AUTHOR) Belgebilgin.gokce@mayo.edu, Burkett, Brian J.1 (AUTHOR), Bilgin, Cem1 (AUTHOR), Durski, Jolanta M.1 (AUTHOR), Packard, Ann T.1 (AUTHOR), Navin, Patrick J.1 (AUTHOR), Thorpe, Matthew P.1 (AUTHOR), Johnson, Derek R.1 (AUTHOR), Johnson, Geoffrey1,2 (AUTHOR), Halfdanarson, Thorvardur R.3 (AUTHOR), Ryder, Mabel4 (AUTHOR), Kendi, Ayse Tuba1 (AUTHOR) |
| Source: | Journal of Nuclear Medicine. Jan2026, Vol. 67 Issue 1, p96-104. 9p. |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
